MKC
54
3
MPC
28
3
CCI
30
2
VRSN
59
4
EIX
61
8
GIS
47
13
ZTS
38
4
COF
48
3
TROW
37
8
MSFT
55
2
VMC
41
2
COP
36
2
LMT
29
-5
EMN
40
5
TMO
52
8
AMP
43
2
SYF
78
7
UHS
50
4
BXP
39
5
NTRS
35
10
MKC
54
3
MPC
28
3
CCI
30
2
VRSN
59
4
EIX
61
8
GIS
47
13
ZTS
38
4
COF
48
3
TROW
37
8
MSFT
55
2
VMC
41
2
COP
36
2
LMT
29
-5
EMN
40
5
TMO
52
8
AMP
43
2
SYF
78
7
UHS
50
4
BXP
39
5
NTRS
35
10
Financhill
Back

Greenlight Capital Re Vs. Novo Nordisk AS Industry Stock Comparison

Buy
60

GLRE
Greenlight Capital Re

Last Price:
$13.84
Seasonality Move:
2.45%
Sell
13

NONOF
Novo Nordisk AS

Last Price:
$84.75
Seasonality Move:
6.94%
Buy
60
Greenlight Capital Re (GLRE) is a Buy

Is Greenlight Capital Re a Buy, Sell or Hold?

  • The current Greenlight Capital Re [GLRE] share price is $13.90. The Score for GLRE is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • GLRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
13
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

GLRE Stock Price Chart

What is Greenlight Capital Re's stock price today?

  • The Greenlight Capital Re share price today is $13.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLRE is experiencing slight buying pressure.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $84.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

GLRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 30.72 Sell
Chaikin Money Flow: 48947 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.37 - 15.09) Sell
Bollinger Bands (100): (13.22 - 14.62) Sell

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.51 Sell
Relative Strength Index (14 RSI): 24.55 Sell
Chaikin Money Flow: 64911 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.57 - 111.43) Sell
Bollinger Bands (100): (107.18 - 131.16) Sell

GLRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.39 Sell
20-day SMA: 14.74 Sell
50-day SMA: 14.33 Sell
200-day SMA: 13.3 Buy
8-day EMA: 14.28 Sell
20-day EMA: 14.52 Sell
50-day EMA: 14.37 Sell
200-day EMA: 13.34 Buy

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.03 Sell
20-day SMA: 106.85 Sell
50-day SMA: 109.33 Sell
200-day SMA: 126.14 Sell
8-day EMA: 102.09 Sell
20-day EMA: 105.65 Sell
50-day EMA: 110.06 Sell
200-day EMA: 118.01 Sell

Greenlight Capital Re Earnings Growth & GLRE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Greenlight Capital Re Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):